95 results
Page 2 of 5
6-K
EX-99.1
6lol0cgk 1hr2
7 Feb 22
Current report (foreign)
2:40pm
6-K
EX-99.1
3mh6et1x5
27 Jan 22
Galapagos appoints Paul Stoffels as Chief Executive Officer
12:00am
6-K
EX-99.1
2cfxi
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
EX-99.1
bczxd3
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
a4oxixp8ybrhih
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
EX-99.1
7umqst
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.1
fzbhzd78 kn91
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
i1ma11 wh
20 Sep 21
Current report (foreign)
9:26am
6-K
EX-99.1
xrq05531jk7o9
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.1
i4e1uxapx7zhl4
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
yvfbesr8wctbbbiwl3xf
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
EX-99.1
ifsy3 3j3ultxaxks0
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
saib3ag83defb53u 9ex
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.1
5ntv0a79
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
7zipbjz2 t7xqh5lb
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
tjccmozvri4z771
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
021y9plf1
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
rnfridhvm1p
23 Apr 21
Current report (foreign)
6:05am
6-K
EX-99.1
04exw x47
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am